APPLICATION SITE JOINT SWELLING

APPLICATION SITE JOINT SWELLING was reported 5 times

APPLICATION SITE JOINT SWELLING is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Aryl Hydrocarbon Receptor Agonist [EPC] 1 0.0005
1 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
2 Microtubule Inhibitor [EPC] 1 0.0000
3 Alkylating Drug [EPC] 1 0.0000
4 Factor Xa Inhibitor [EPC] 1 0.0000